Cal-Maine Foods is expected to report Q4 2026 revenue of $606.0 million and earnings per share of $0.42, with the stock currently trading at $88.55 against a consensus analyst target of $94.29. Investors are primarily focused on the specialty egg sales mix as a critical indicator of the company’s transition toward higher-margin, less volatile product categories.
While revenue is projected to decline approximately 45% year-over-year from the record pricing peaks of fiscal 2025, the expansion of the prepared foods segment is expected to stabilize the long-term earnings floor. Management’s commentary regarding ongoing H5N1 avian influenza supply disruptions and the implications of the recent $1.5 million DOJ price-fixing settlement will also be central to the quarterly narrative.